Showing results (51-60 of 183) with videos related to

Sort By:
Pageof 19
Tomography (Ann Arbor, Mich.)|October 26, 2022
Prostate Cancer Biochemical Recurrence Resulted Negative on [68Ga]Ga-PSMA-11 but Positive on [18F]Fluoromethylcholine PET/CTRiccardo Laudicella, Flavia La Torre, Valerio Davì, et al.
The International Journal of Cardiovascular Imaging|February 14, 2025
Is cardiopulmonary transit time (CPTT) measured by using dynamic rubidium cardiac PET/CT a predictor for cardiac function?Lena C Seige, Boya Zhang, Jakob Heimer, et al.
European Journal of Hybrid Imaging|June 30, 2021
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysisSungmin Woo, Soleen Ghafoor, Anton S Becker, et al.
EJNMMI Research|July 29, 2018
Quantitative performance and optimal regularization parameter in block sequential regularized expectation maximization reconstructions in clinical 68Ga-PSMA PET/MREdwin E G W Ter Voert, Urs J Muehlematter, Gaspar Delso, et al.
Nuclear Medicine and Biology|March 27, 2014
PET quantification with a histogram derived total activity metric: superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patientsIrene A Burger, Hebert Alberto Vargas, Aditya Apte, et al.
Nuklearmedizin. Nuclear Medicine|July 8, 2026
Frequency and new-onset rates of nausea and fatigue in ¹⁷⁷Lu-PSMA therapy with standardized premedicationWolfram A Bosbach, Karene Sriramachandran, Nasir Gözlügöl, et al.
Cancers|August 7, 2021
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma PatientsKen Kudura, Florentia Dimitriou, Lucas Basler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
PET/MR imaging of bone lesions--implications for PET quantification from imperfect attenuation correctionAndrei Samarin, Cyrill Burger, Scott D Wollenweber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2016
18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic ResponseIrene A Burger, Ruben Casanova, Seraina Steiger, et al.
Nuclear Medicine Communications|December 5, 2013
How to assess background activity: introducing a histogram-based analysis as a first step for accurate one-step PET quantificationIrene A Burger, Hebert A Vargas, Brad J Beattie, et al.
Pageof 19